Glycoproteins are potential biomarkers for inflammation (Otvos et al., 2015) and our results suggest that signals belonging to N-acetyl and O-acetyl groups from glycoproteins could be use as markers for pneumonia and in particular VAP. The gene discussed is ART4; the disease is susceptibility to pneumonia measurement.